Document is current
Any future updates will be listed below
-
Authors
Readhead, Benjamin https://orcid.org/0000-0003-4353-9965
Klang, Eyal
Gisladottir, Undina
Vandromme, Maxence
Li, Li
Quiroz, Yakeel T. https://orcid.org/0000-0001-9714-8244
Arboleda-Velasquez, Joseph F.
Dudley, Joel T.
Tatonetti, Nicholas P.
Glicksberg, Benjamin S.
Reiman, Eric M. https://orcid.org/0000-0002-0705-3696
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R01AG054671)
- License Information
-
More Information
Article History
Received: 30 August 2023
Revised: 5 September 2024
Accepted: 13 September 2024
First Online: 8 October 2024
Competing interests
: YTQ reports consulting fees from Biogen. YTQ, JFAV, EMR are listed as co-inventors of a patent application for therapeutics modulating interactions between APOE and HSPG filed by MGB.
: This retrospective cohort study received Institutional Review Board (IRB) approval from all participating institutions (MSHS: 19-00951, CUMC: AAAL0601). In both cases, the IRB committee waived informed consent.
